Preoperative risk stratification using metabolic parameters of (18)F-FDG PET/CT in patients with endometrial cancer. (Q53017777)

10 May 2018

title

Preoperative risk stratification using metabolic parameters of (18)F-FDG PET/CT in patients with endometrial cancer. (English)

1 reference

10 May 2018

6

Hideto Yamada

1 reference

10 May 2018

Yasuhiko Ebina

5

object named as

Yasuhiko Ebina

1 reference

10 May 2018

author name string

Kazuhiro Kitajima

1

1 reference

10 May 2018

Yuko Suenaga

2

1 reference

10 May 2018

Yoshiko Ueno

3

1 reference

10 May 2018

Tetsuo Maeda

4

1 reference

10 May 2018

Takashi Okunaga

7

1 reference

10 May 2018

Kazuhiro Kubo

8

1 reference

10 May 2018

Keitarou Sofue

9

1 reference

10 May 2018

Tomonori Kanda

10

1 reference

10 May 2018

Yukihisa Tamaki

11

1 reference

10 May 2018

Kazuro Sugimura

12

1 reference

10 May 2018

publication date

2 April 2015

1 reference

10 May 2018

European Journal of Nuclear Medicine and Molecular Imaging

published in

1 reference

10 May 2018

volume

42

1 reference

10 May 2018

issue

8

1 reference

10 May 2018

page(s)

1268-1275

1 reference

10 May 2018

https://scigraph.springernature.com/pub.10.1007/s00259-015-3037-2

exact match

0 references

cites work

Current issues in the management of endometrial cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3037-2

Contemporary management of endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3037-2

Functional images reflect aggressiveness of endometrial carcinoma: estrogen receptor expression combined with 18F-FDG PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3037-2

The SUVmax of 18F-FDG PET correlates with histological grade in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3037-2

The measurement of SUVmax of the primary tumor is predictive of prognosis for patients with endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3037-2

Prognostic significance of SUVmax (maximum standardized uptake value) measured by [¹⁸F]FDG PET/CT in endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3037-2

SUVmax of 18FDG PET/CT as a predictor of high-risk endometrial cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3037-2

The preoperative maximum standardized uptake value measured by 18F-FDG PET/CT as an independent prognostic factor of overall survival in endometrial cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3037-2

Risk stratification and prognosis determination using (18)F-FDG PET imaging in endometrial cancer patients: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3037-2

Prognostic value of metabolic tumor volume and total lesion glycolysis in head and neck cancer: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3037-2

Prognostic value of preoperative metabolic tumor volume measured by ¹⁸F-FDG PET/CT and MRI in patients with endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3037-2

Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3037-2

Metabolic tumour volume and total lesion glycolysis, measured using preoperative 18F-FDG PET/CT, predict the recurrence of endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3037-2

Segmentation of positron emission tomography images: some recommendations for target delineation in radiation oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3037-2

Fifteen different 18F-FDG PET/CT qualitative and quantitative parameters investigated as pathological response predictors of locally advanced rectal cancer treated by neoadjuvant chemoradiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3037-2

Which FDG/PET parameters of the primary tumors in colon or sigmoid cancer provide the best correlation with the pathological findings?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3037-2

Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3037-2

Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study

21 January 2018

1 reference

12 December 2020

Preoperative risk stratification using (18)F-FDG PET/CT in women with endometrial cancer

1 reference

12 December 2020

FDG PET for the assessment of myometrial infiltration in clinical stage I uterine corpus cancer

1 reference

12 December 2020

1 reference

12 December 2020

Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium

1 reference

12 December 2020

FDG PET/CT diagnostic criteria may need adjustment based on MRI to estimate the presurgical risk of extrapelvic infiltration in patients with uterine endometrial cancer

1 reference

12 December 2020

Metabolic tumor volume by 18F-FDG PET/CT is prognostic for stage IVB endometrial carcinoma

1 reference

12 December 2020

10.1007/S00259-015-3037-2

Identifiers

DOI

1 reference

10 May 2018

PubMed ID

25833351

1 reference

10 May 2018